Geneial is pleased to announce its award of a Phase II grant from the National Institutes of Health (NIH), specifically from the National Human Genome Research Institute (NHGRI). This signifies a significant milestone in our ongoing pursuit of advancing rare disease research and contributing to… Read More »Geneial Receives Phase II SBIR Grant to Build Rare Disease Communities
HOUSTON, Sept. 22, 2022 /PRNewswire/ — Healthtech company Geneial announces amultimillion dollar, non-dilutive award from the National Human Genome Research Instituteto fund the development of their secure, decentralized platform. Geneial’s platform will connect researchers of rare genetic diseases with relevant data whilepreserving patient privacy. Geneial’s… Read More »Geneial Receives $2.3M NIH Grant
Geneial and Baylor College of Medicine Report Success in Initial Collaborative Project HOUSTON, Jan. 12, 2022 — Geneial is excited to announce the completion of phase I of our partnership with the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC), through which we have… Read More »Geneial Announces Partnership with HGSC